Brian Cusworth

Targeting tumour-associated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial

Timothy M. Nywening, Andrea Wang‐Gillam, Dominic E. Sanford et al. · The Lancet Oncology · 2016 · 746 citations · Full text

Pancreatic Cancer, Tumour-associated Macrophages, Medicine +8

Preoperative Anxiety Effect on Patient-Reported Outcomes Following Foot and Ankle Surgery

Devon Nixon, Kevin A. Schafer, Brian Cusworth et al. · Foot & Ankle International · 2019 · 45 citations

Whipple-specific complications result in prolonged length of stay not accounted for in ACS-NSQIP Surgical Risk Calculator

Brian Cusworth, Bradley A. Krasnick, Timothy M. Nywening et al. · HPB · 2016 · 44 citations · Full text

Surgical Quality Control, Adverse Event, Patient Safety +7

Renal Mass Imaging with MRI Clear Cell Likelihood Score: A User’s Guide

Anup S. Shetty, Tyler J. Fraum, David H. Ballard et al. · Radiographics · 2023 · 24 citations

Patient-Reported Allergies Do Not Predict Poorer PROMIS Function, Pain, and Depression Scores Following Foot and Ankle Surgery

Devon Nixon, Brian Cusworth, Jeremy J. McCormick et al. · Foot & Ankle International · 2018 · 13 citations